COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some e...

Full description

Saved in:
Bibliographic Details
Main Authors LOREN, JON, NGUYEN, BAO, LI, XIAOLIN, LIU, XIAODONG, PETRASSI, HANK MICHAEL JAMES, NABAKKA, JULIET, YEH, VINCE, MOLTENI, VALENTINA
Format Patent
LanguageEnglish
French
Published 03.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRa, PDGFRß) kinases. La présente invention concerne des composés de formule (I) et (II) et des compositions pharmaceutiques en contenant, pouvant être utilisés en tant qu'inhibiteurs des protéines kinases, ainsi que des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention d'une affection associée à une activité anormale ou dérégulée des kinases. Dans certains modes de réalisation, l'invention concerne des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention des maladies ou affections impliquant une activation anormale des kinases c-kit ou c-kit et PDGFR (PDGFRa, PDGFRß).
AbstractList The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRa, PDGFRß) kinases. La présente invention concerne des composés de formule (I) et (II) et des compositions pharmaceutiques en contenant, pouvant être utilisés en tant qu'inhibiteurs des protéines kinases, ainsi que des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention d'une affection associée à une activité anormale ou dérégulée des kinases. Dans certains modes de réalisation, l'invention concerne des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention des maladies ou affections impliquant une activation anormale des kinases c-kit ou c-kit et PDGFR (PDGFRa, PDGFRß).
Author LIU, XIAODONG
LOREN, JON
YEH, VINCE
NGUYEN, BAO
PETRASSI, HANK MICHAEL JAMES
MOLTENI, VALENTINA
LI, XIAOLIN
NABAKKA, JULIET
Author_xml – fullname: LOREN, JON
– fullname: NGUYEN, BAO
– fullname: LI, XIAOLIN
– fullname: LIU, XIAODONG
– fullname: PETRASSI, HANK MICHAEL JAMES
– fullname: NABAKKA, JULIET
– fullname: YEH, VINCE
– fullname: MOLTENI, VALENTINA
BookMark eNrjYmDJy89L5WQwdfb3DfAP9XMJVnD0c1EA84I9Qzz9_YACwQrOut6eIQrenn6Owa4Knn4enk6eIf5BwTwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JN7Z0cjCxNTQ1NLZmLAKAFM_KJg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES ET COMPOSITIONS POUVANT ETRE UTILISES EN TANT QU'INHIBITEURS DE LA KINASE C-KIT
ExternalDocumentID CA2845159C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2845159C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2845159C3
Notes Application Number: CA20122845159
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&CC=CA&NR=2845159C
ParticipantIDs epo_espacenet_CA2845159C
PublicationCentury 2000
PublicationDate 20201103
PublicationDateYYYYMMDD 2020-11-03
PublicationDate_xml – month: 11
  year: 2020
  text: 20201103
  day: 03
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies IRM LLC
RelatedCompanies_xml – name: IRM LLC
Score 3.2947671
Snippet The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&locale=&CC=CA&NR=2845159C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2VgoAbFFDZfUC5RajU2Q4RSuxECSiLmhT1VjnFFVzSigbx-9gmAS69eZHG9kgzz8u8McCdTPFk2JWjO7bJdGyZC93GjOmcGwJPljb7YXgnqRlN8dPMmPXgrePCqDyhXyo5orCohbD3Rvnr9d8lFlWxlZv76l00rR7D0qVaezpWaDbWqO8GeUYzohHiEk9LJ67wwhK5yQ7sik20JW0hePElJ2X9H1DCI9jLhay6OYYerwdwQLp_1wawn7TP3aLYWt7mBAySJXk2TWmBvJQiVStixQFGXoGI_hyXSBzFvSJAcRrFflxmk-IUbsOgJJEuxp__LnVOvG6i4zPo16uaDwHJSEyHYQdz6xUv2aga8QfLqphMrGLY3DmH4TYpF9u7LuFQKkzx6sZX0G8-Pvm1ANimulG6-QZ2SXnm
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2Vgig3KKCy1geUW4RKsx4ilDiJEtosalLUW-S0ruCSVjSI38c2CXDpzYs0tkeaeV7mjQEeeIon1ShN2TQ0Iiu6tpQNhRCZUpXhydogPwzvKNaCufKyUBcdeGu5MCJP6JdIjsgsasnsvRb-evt3ieWK2MrdY_nOmjbPfm65UnM6Fmg2llzH8tLETbCEsYVtKZ5ZzAtz5MYHcMg22Dq3Be_V4ZyU7X9A8U_hKGWyqvoMOrTqQw-3_6714ThqnrtZsbG83TmoOInSZB67GbJjF4laFgoOMLIzhOVJmCN2FLczD4VxEDphnsyyCxj6Xo4DmY1f_C61wHY70fEldKtNRQeAeCSmSRRTofpKWZNROaJPul4SnlhFNah5BYN9Uq73dw2hF-TRtJiG8eQGTrjyBMdufAvd-uOT3jGwrct7oadvWUl82Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+AND+COMPOSITIONS+AS+C-KIT+KINASE+INHIBITORS&rft.inventor=LOREN%2C+JON&rft.inventor=NGUYEN%2C+BAO&rft.inventor=LI%2C+XIAOLIN&rft.inventor=LIU%2C+XIAODONG&rft.inventor=PETRASSI%2C+HANK+MICHAEL+JAMES&rft.inventor=NABAKKA%2C+JULIET&rft.inventor=YEH%2C+VINCE&rft.inventor=MOLTENI%2C+VALENTINA&rft.date=2020-11-03&rft.externalDBID=C&rft.externalDocID=CA2845159C